BAY 81‐8973 prophylaxis and pharmacokinetics in haemophilia A: Interim results from the TAURUS study

OBJECTIVES: To report interim data from TAURUS, a study assessing real‐world prophylactic treatment with unmodified, full‐length recombinant FVIII BAY 81‐8973 (Kovaltry(®); Bayer) indicated for haemophilia A. METHODS: TAURUS (NCT02830477) is an international, open‐label, prospective, non‐interventio...

Descripción completa

Detalles Bibliográficos
Autores principales: Santoro, Cristina, Fuh, Beng, Le, Phu Quoc, Maes, Philip, Berrueco, Rubén, Mingot‐Castellano, Eva Maria, von Mackensen, Sylvia, Solms, Alexander, Wang, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497079/
https://www.ncbi.nlm.nih.gov/pubmed/32259334
http://dx.doi.org/10.1111/ejh.13420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497079/
https://www.ncbi.nlm.nih.gov/pubmed/32259334
http://dx.doi.org/10.1111/ejh.13420

Ejemplares similares